Results 111 to 120 of about 16,497 (212)

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Obesity, Volume 34, Issue 6, Page 1210-1229, June 2026.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source

Let's Talk About Sex: A Systematic Review of What Childhood Cancer Patients and Survivors Really Want to Know About Sex

Psycho-Oncology, Volume 35, Issue 6, June 2026.
ABSTRACT Background Childhood cancer treatment often leads to persistent, complex psychosexual late effects, which impact survivors' sexual function, body image, and relational development. Despite these pervasive and serious consequences, sexual health communication remains consistently neglected across the cancer care continuum for childhood cancer ...
Victoire Terlinden, María‐del‐Mar Aires‐González, Francisco‐Javier Cano‐García   +2 more
wiley   +1 more source

Implementing a Co‐Produced Women's Health Programme in an Integrated Care System

Public Health Challenges, Volume 5, Issue 2, June 2026.
A co‐produced women's health programme is implemented within an integrated care system using a structured, six‐phase service improvement approach. Engagement with over 1200 participants identifies barriers, priorities, and service gaps. Findings inform the co‐design of five targeted service models.
Susan Conquer, Lizzie Mapplebeck, Annetta Bradshaw, Lisa Nobes, Camille Cronin   +4 more
wiley   +1 more source

Exploring Knowledge, Availability, Accessibility, and Utilization of Emergency Contraception in Ghana: A Scoping Review. [PDF]

Cureus
Asare O, Osuagwu SC, Dixit A, Foster AM.
europepmc   +1 more source

Trends in Maternal Mortality in Bhutan: A National Review, 1985 to 2024

Reproductive, Female and Child Health, Volume 5, Issue 2, June 2026.
ABSTRACT Background Maternal mortality remains a major global public health concern, with the highest burden in low‐ and middle‐income countries. Despite global progress, preventable causes such as hemorrhage and hypertensive disorders continue to contribute significantly to maternal deaths.
Yeshey Dorjey, Deep Kiran Chhetri, Thinley Dorji, Sonam Gyamtsho   +3 more
wiley   +1 more source

Knowledge and attitudes toward emergency contraception among pharmacy students and community pharmacists in Poland. [PDF]

Front Public Health
Czekajewska J, Walkowiak D, Jelińska A, Domaradzki J.   +3 more
europepmc   +1 more source

A Phase 1 Microtracer Study Evaluating the Mass Balance, Excretion, and Pharmacokinetics of Osivelotor in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Osivelotor (GBT021601) is an orally bioavailable, small molecule hemoglobin polymerization inhibitor in clinical development for the treatment of sickle cell disease (SCD). In this Phase 1 study, the disposition of osivelotor was assessed using accelerator mass spectrometry (AMS) after a single oral 200‐mg dose containing a microtracer amount ...
Eric I. Zimmerman, Ernesto Callegari, Raman Sharma, Adeyemi Adenola, Jessica Volpe, Karthik Seetharaman, Chenghong Zhang, Kenneth Duchin, Gregory S. Walker   +8 more
wiley   +1 more source

Availability of Oral Emergency Contraception in German Community Pharmacies-A Nationwide Cross-Sectional Mystery Caller Study. [PDF]

Health Sci Rep
Kunow C, Priepke C, Langer B.
europepmc   +1 more source

Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT The aim of this study was to determine the cerebrospinal fluid (CSF) to plasma concentration ratio of atogepant. Healthy adult participants (N = 28) were enrolled into this phase 1, open‐label study and received atogepant 60 mg once daily for 8 days. Steady‐state atogepant concentrations were determined from CSF samples collected on Day 6 at 2
Ramesh R. Boinpally, Joel M. Trugman
wiley   +1 more source

Emergency contraception in primary health care. [PDF]

S Afr Fam Pract (2004)
Govender I, Adeleke OA, Govender LL, Omole OB.   +3 more
europepmc   +1 more source